Literature DB >> 8130049

A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients.

T G Short1, C S Aun, P Tan, J Wong, Y H Tam, T E Oh.   

Abstract

We have tested a published algorithm for pharmacokinetic model controlled infusion of propofol to supplement 67% nitrous oxide for general anaesthesia in Chinese children aged 4-10 yr. Initially we studied 10 children undergoing minor procedures with spontaneous ventilation; mean duration of surgery was 38 min and mean propofol infusion rate 497 micrograms kg-1 min-1. The precision of the model was 24.8% and bias -18.5%. The model was revised using an iterative linear least squares regression procedure and the revised model tested prospectively in another 20 children. The precision of the revised model was 21.5% (range in individuals 8.4-43.1%) and bias -0.1% (range -30 to 42%). Mean propofol infusion rate required to maintain anaesthesia was 474 micrograms kg-1 min-1 (range 125-737 micrograms kg-1 min-1). The mean blood concentration required for satisfactory anaesthesia was 6.6 micrograms ml-1 (range 3-11 micrograms ml-1) and the mean blood concentration at the time of waking, which occurred 40 min after switching off the infusion, 0.86 microgram ml-1 (range 0.40-1.45 micrograms ml-1). Our patient population required different pharmacokinetic variables from those in the previous study. Recovery was slow because of the high infusion rates required to maintain satisfactory anaesthesia and large difference between the blood concentration required for anaesthesia and that at which waking occurred.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8130049     DOI: 10.1093/bja/72.3.302

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  13 in total

1.  Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children.

Authors:  Byung-Moon Choi; Hyun-Gu Lee; Hyo-Jin Byon; Soo-Han Lee; Eun-Kyung Lee; Hee-Soo Kim; Gyu-Jeong Noh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-02-28       Impact factor: 2.745

2.  Intravenous anesthetic propofol binds to 5-lipoxygenase and attenuates leukotriene B4 production.

Authors:  Toshiaki Okuno; Sophia Koutsogiannaki; Mai Ohba; Matthew Chamberlain; Weiming Bu; Fu-Yan Lin; Roderic G Eckenhoff; Takehiko Yokomizo; Koichi Yuki
Journal:  FASEB J       Date:  2017-01-09       Impact factor: 5.191

3.  Propofol Suppresses LPS-Induced Inflammation in Amnion Cells via Inhibition of NF-κB Activation.

Authors:  Ji-Young Yoon; Do-Wan Kim; Ji-Hye Ahn; Eun-Ji Choi; Yeon Ha Kim; Moonjung Jeun; Eun-Jung Kim
Journal:  Tissue Eng Regen Med       Date:  2019-05-29       Impact factor: 4.169

4.  Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia.

Authors:  Mian Peng; Ji-Shi Ye; Yan-Lin Wang; Chang Chen; Cheng-Yao Wang
Journal:  Inflamm Res       Date:  2014-02-01       Impact factor: 4.575

5.  Sedative drug modulates T-cell and lymphocyte function-associated antigen-1 function.

Authors:  Koichi Yuki; Sulpicio G Soriano; Motomu Shimaoka
Journal:  Anesth Analg       Date:  2011-03-08       Impact factor: 5.108

6.  Propofol directly binds to and inhibits TLR7.

Authors:  Sophia Koutsogiannaki; Weiming Bu; Wiriya Maisat; Mariel Manzor; Zhikuan Zhang; Umeharu Ohto; Roderic G Eckenhoff; Koichi Yuki
Journal:  FASEB J       Date:  2022-08       Impact factor: 5.834

Review 7.  [Total intravenous anesthesia. On the way to standard practice in pediatrics].

Authors:  J M Strauss; J Giest
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

8.  Comparative performance of oral midazolam clearance and plasma 4β-hydroxycholesterol to explain interindividual variability in tacrolimus clearance.

Authors:  Thomas Vanhove; Hylke de Jonge; Henriëtte de Loor; Pieter Annaert; Ulf Diczfalusy; Dirk R J Kuypers
Journal:  Br J Clin Pharmacol       Date:  2016-09-20       Impact factor: 4.335

Review 9.  Why do We Use the Concepts of Adult Anesthesia Pharmacology in Developing Brains? Will It Have an Impact on Outcomes? Challenges in Neuromonitoring and Pharmacology in Pediatric Anesthesia.

Authors:  Pablo O Sepúlveda; Valeria Epulef; Gustavo Campos
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

10.  Volatile anesthetics, not intravenous anesthetic propofol bind to and attenuate the activation of platelet receptor integrin αIIbβ3.

Authors:  Koichi Yuki; Weiming Bu; Motomu Shimaoka; Roderic Eckenhoff
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.